Home
Resources
Diseases
COVID-19
Ebola
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hepatitis B birth dose vaccines
Hexavalent vaccines
HPV vaccines
Malaria vaccines
Measles containing vaccines
PCV vaccines
RSV vaccines
Typhoid Conjugate Vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (359)
Reports (2)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1199)
Regions
Africa (62)
Americas (192)
Eastern Mediterranean (12)
Europe (161)
Global (1)
South-East Asia (12)
Western Pacific (39)
Diseases
COVID-19 (1599)
Chikungunya (13)
Cholera (35)
Cytomegalovirus (1)
Dengue (45)
Diphtheria (92)
Ebola (21)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (72)
Hepatitis A (71)
Hepatitis B (175)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (81)
HIV / AIDS (10)
Human papillomavirus (HPV) (545)
Influenza (639)
Japanese encephalitis (35)
Lyme disease, Borreliosis (2)
Malaria (35)
Measles (148)
Meningococcal disease (157)
Moraxella catarrhalis (1)
Mpox (59)
Mumps (53)
Pertussis (122)
Pneumococcal disease (310)
Poliomyelitis (98)
Q fever (1)
Rabies (33)
Rotavirus (122)
RSV (Respiratory syncytial virus) (71)
Rubella (72)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (73)
Tick-borne encephalitis (14)
Tuberculosis (84)
Typhoid (33)
Varicella (79)
Yellow fever (45)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (14)
Moderate (9)
Low (132)
Critically low (732)
Not applicable (312)
1599 results found
2020
∙
ACIP
Operation warp speed: Overview of COVID Vaccine Efficacy Trials
2020
∙
Jacqueline Miller
Overview of Moderna’s COVID-19 Vaccine (mRNA-1273)
2020
∙
Sara Oliver, ACIP
Overview of Vaccine Equity and Prioritization Frameworks
2020
∙
Kathleen Dooling, ACIP
Phase 1 allocation COVID-19 vaccine: Work Group considerations
2020
∙
Kathleen Dooling, ACIP
Phased Allocation of COVID-19 Vaccines
2020
∙
Kathleen Dooling, ACIP
Phased Allocation of COVID-19 Vaccines
2020
∙
Kathleen Dooling, ACIP
Phased Allocation of COVID-19 Vaccines
2020
∙
ATAGI
Preliminary advice on general principles to guide the prioritisation of target populations in a COVID-19 vaccination program in Australia
2020
∙
NACI, Public Health Agency of Canada
Preliminary guidance on key populations for early COVID-19 immunization
2020
∙
JCVI
Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI, 25 September 2020
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register